Invention Grant
US08524232B2 Methods of treatment using taci-immunoglobulin fusion proteins
有权
使用taci-免疫球蛋白融合蛋白的治疗方法
- Patent Title: Methods of treatment using taci-immunoglobulin fusion proteins
- Patent Title (中): 使用taci-免疫球蛋白融合蛋白的治疗方法
-
Application No.: US13105182Application Date: 2011-05-11
-
Publication No.: US08524232B2Publication Date: 2013-09-03
- Inventor: Mark W. Rixon , Jane A. Gross
- Applicant: Mark W. Rixon , Jane A. Gross
- Applicant Address: US WA Seattle
- Assignee: Zymogenetics, Inc.
- Current Assignee: Zymogenetics, Inc.
- Current Assignee Address: US WA Seattle
- Agency: Alston & Bird LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C12P21/08
Abstract:
Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.
Public/Granted literature
- US20110229473A1 METHODS FOR USING TACI-IMMUNOGLOBULIN FUSION PROTEINS Public/Granted day:2011-09-22
Information query
